Bacteriological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer.
Sponsor: Yanhong Deng
A observational or N/A phase clinical study on Rectum Cancer, this trial is ongoing. The trial is conducted by Yanhong Deng and has accumulated 5 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Mar 2022 — Feb 2024 [monthly]
Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Recruiting
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yanhong Deng
For direct contact, visit the study record on ClinicalTrials.gov .